Our latest news

Heidelberg/Germany, May 27, 2025. RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will commercialize RHEACELL’s two stem cell products, EBESANAR® and AMESANAR®, in Europe, Turkey, Israel and the MENA region (Middle East and Northern Africa). RHEACELL retains full commercialization rights to EBESANAR® and AMESANAR® in […]

Scientists at the German Cancer Research Center (DKFZ) have shown in an international eye-tracking study that dermatologists not only improve their diagnostic accuracy by using explainable artificial intelligence, but also show significantly less fatigue when assessing challenging cases. The researchers were able to demonstrate this by measuring a reduction in cognitive stress indicators. In a […]

How do stellar explosions or the evolution of galaxies influence our universe today? How can synthetic biology and specially designed cells aid in the protection of our immune system against infections and cancer? Tackling these research questions from different disciplines is the endeavor of two projects that have been selected as Clusters of Excellence in the […]

Funding for research projects at the highest level internationally In the context of the Excellence Strategy of the Federal and State Governments, Heidelberg University has been successful with three applications in the Cluster of Excellence funding line. According to the decision on selection announced today (Thursday 22 May 2025), not only will the existing cluster […]

Steinbrenner Laborsysteme is focused on delivering tailored services and high-quality products with fast, reliable delivery and personal, solution-oriented communication. Backed by a global supplier network and expert staff, it offers custom mechanical parts, injection molding, and molecular biology solutions. Whether for single prototypes or full-scale production, the team provides individualized support to meet specific customer […]

Many people are infected with the Epstein-Barr virus (EBV), and most are unaware of it. However, EBV can sometimes cause cancer, and this pathogen also appears to play an important role in multiple sclerosis and other autoimmune diseases. Researchers at the German Cancer Research Center (DKFZ) and the Kidney Center at Heidelberg University Hospital have […]

Peer Fischer, research group leader at the Max Planck Institute for Medical Research in Heidelberg and Professor at the Institute for Molecular Systems Engineering and Advanced Materials at Heidelberg University, has been elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). “The appointment is a great honor,” says Peer Fischer. ”I […]

The reservoir of blood stem cells shrinks with age. It becomes increasingly dominated by stem cells that produce immune cells associated with chronic inflammation. Almost all of the 60-year-olds studied show this change. Researchers from the Centre for Genomic Regulation and the Institute for Research in Biomedicine, both in Barcelona, and the German Cancer Research […]

World Novelty: Artificial HPL Solution First Artificial Human Platelet Lysate BioScience Raises the Bar in Cell Culture Technology with artificial HPL PL BioScience develops worldwide first artificial Human Platelet Lysate (HPL) solution, and thus a key ingredient for the research & production of cell-based pharmaceuticals. In partnership with the Korean biotech DewCell Biotherapeutics, PL BioScience […]